Evidence map›Paper›PMID 39490244›Full record

ArticleClinical lung cancer2025

Implementation and Retrospective Examination of a Lung Cancer Survivorship Clinic in a Comprehensive Cancer Center.

Sarah N Price, Alana R Willis, Amy Hensley, Jill Hyson, Stephanie J Sohl, Ralph B D'Agostino, Michael Farris, W Jeffrey Petty, Alberto de Hoyos, Kathryn E Weaver and 1 more

Abstract read
In one paragraph

Article in Clinical lung cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Models, outcomes, barriers, and facilitators of supportive care in cancer: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah N PriceDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine. Electronic address: sarahpr@wakehealth.edu.
Alana R WillisDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine.
Amy HensleyDepartment of Radiation Oncology, Atrium Health Wake Forest Baptist.
Jill HysonDepartment of Hematology Oncology, Atrium Health Wake Forest Baptist.
Stephanie J SohlDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine.
Ralph B D'AgostinoDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine.
Michael FarrisDepartment of Radiation Oncology, Atrium Health Wake Forest Baptist.
W Jeffrey PettyDepartment of Hematology Oncology, Atrium Health Wake Forest Baptist.
Alberto de HoyosDepartment of Cardiothoracic Surgery, Atrium Health Wake Forest Baptist.
Kathryn E WeaverDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine.
Stacy WentworthDepartment of Radiation Oncology, Atrium Health Wake Forest Baptist.

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
iDAPT: Implementation and Informatics - Developing Adaptable Processes and Technologies for Cancer Control P50CA244693 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CUTRONA, SARAH LELEIKO, FOLEY, KRISTIE L · 2019 to 2023
$4.1M
Postdoctoral Training Program in Cancer SurvivorshipR25CA122061 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI AVIS, NANCY E · 2008 to 2018
$3.8M
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patientsR01CA262041 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jennifer Lynne Huberty, Ruben A. Mesa · 2022 to 2026
$2.8M
Cancer Prevention And Control Training Grant (CAPACITY)T32CA122061 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KRISTIE L FOLEY, Kathryn Elizabeth Weaver · 2019 to 2026
$2.1M
NCI NIH HHS P30 CA012197NCI NIH HHS P50 CA244693NCI NIH HHS R01 CA262041NCI NIH HHS R25 CA122061NCI NIH HHS T32 CA122061
6 · The paper itself

Abstract

purposeThe number of early-stage lung cancer survivors (LCS) is increasing, yet few survivorship programs address their specific needs. We developed a workflow to transition early-stage LCS to dedicated lung survivorship care and comprehensively identify and address their needs using electronic patient-reported outcomes (ePROs).

methodsA lung cancer multidisciplinary team developed a workflow (eg, referrals, survivorship care plan delivery, documentation, orders, tracking, ePROs, and surveillance) for a survivorship clinic staffed by Advanced Practice Providers (APPs). ePROs included the NCCN Distress Thermometer, PROMIS-29, and investigator-developed patient satisfaction items. Patient characteristics, ePROs, and referrals are described; chi-square and t-tests examined ePRO completion by patient characteristics and compared PROMIS-29 domains by treatment modality and to a national sample.

resultsFrom January 2020-March 2023, 315 early-stage LCS completed a survivorship orientation visit. Patient satisfaction was high; 75% completed ePROs. Females were overall less likely to complete ePROs than males; male, age 65+, Black or other race, and rural patients were more likely to complete ePROs in clinic versus online. Patients reported lower symptom burden compared to a general population of early-stage LCS in the United States; scores were similar regardless of treatment modality. Rates of moderate-severe symptoms ranged from 6% (depression) to 42% (poor physical function); ≤ 20% had a referral placed.

conclusionsA referral-based, APP-staffed survivorship clinic model for early-stage LCS which includes ePROs to identify specific needs is acceptable to patients. Future work should include outreach to female LCS and increasing supportive care referrals and acceptability to further address early-stage LCS reported needs.

Indexed as

Cancer Care FacilitiesCancer SurvivorsLung NeoplasmsSurvivorshipAdultAgedFemaleHumansMaleMiddle AgedPatient Reported Outcome MeasuresPatient SatisfactionRetrospective StudiesSurvival RateCancer survivorsLung neoplasmsPatient reported outcome measuresRadiotherapySymptom burden

Identifiers

PMID39490244
PMCPMC11700753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.